Get started

Regeneron

Regeneron Pharmaceuticals | REGN | Long at $502.28Regeneron Pharmaceuticals NASDAQ:REGN stock dropped more than 17% today due to mixed Phase 3 trial results for itepekimab, a potential COPD drug. However, the company has an extensive drug pipeline, raked in over $14 billion last year, and is currently trading at a price-to-earnings of 15x. Debt-to-equity is 0.09x (extremely healthy) and earnings are forecast to grow 7.5% per year. While 2025 is anticipated to be its "worst" earnings year, the outlook through 2028 looks like steady growth in revenue and cash flow. From a technical analysis view, the stocks entered my "crash" simple moving average zone today (currently between $466 and $502). More often than not, this area signals a bottom in the near-term, but it's not guaranteed. I wouldn't be surprised if the $450s-$460s get hit before a reversal if the market shifts negatively - which will be another entry for me. If it moves into my "major" crash zone in the $300s to close more gaps on the daily chart, I will be piling into this stock heavily (like I did with NYSE:UNH ) for a longer-term hold - of course, unless fundamentals change. I'm going to keep my target small unless there is a "major crash" and eye the closing of the nearest price gap on the daily. There is another between $883-$914... Targets: $590 (+17.5%)
NASDAQ:REGNLong
by WorthlessViews
1
REGN Technical Analysis: Potential Bullish SetupREGN is currently at a strong weekly support level, having formed a double bottom with a clear bullish divergence on the daily chart. The price has also closed above a downward trendline, signaling a potential shift in momentum. While the price might be slightly resistant in the 668 - 686 zone, a strong close above this area could lead to further upside. Trading Recommendations: Entry Point (CMP): 594 Stop-Loss: Closing below 520 Take Profit 1: 686 Take Profit 2: Open Beyond the initial target, other potential targets include 740. After that, the price could look to fill a gap at 914, and potentially even hit 1200 as there appears to be no major resistance before that level. Happy trading!
NASDAQ:REGNLong
by TradeWithParas
ridethepig | Regeneron Pharmaceuticals📌 REGN pipeline (with particular focus on the early stages) CEMIPLIMAB, REGN3767, REGN1979, REGN4018, REGN5458, REGN5459, REGN5678, REGN5093, REGN5713-5714-5715 and REGN-COV2 all have a lot of potential with particular focus around oncology. As can be see with GILD, the covid positioning has already moved on a lot: we are ready to play chapter II and REGN is a name worth considering for those looking to add single stock opps to their portfolio. Buyers are clearly exercising control here on the Monthly chart at $600. To the topside there is very little in-between here and $1,000 as the next big level. Thanks as usual for keeping the feedback coming 👍 or 👎
NASDAQ:REGNLong
by ridethepig
Regeneron (REGN) Is an absolutely massive opportunityHi guys, hope you are well. Today we will be looking at Regeneron, hopefully at this point you understand the basics of Elliot wave and my diagram should be easily explainable. Wave 1 formed nicely with Wave 2 becoming an ending diagonal triangle in a corrective structure. The beginning of wave 3 has formed, and the structure is perfect for an investment opportunity. Usually wave 2 within a 5 wave structure is the sharper correction, and we can see this is proven within the diagram. Now, I see the stock hitting possible lows of 450-435, however as this is not certain, I will be investing at the end of this week, whatever the outcome. Wave 3 is usually the longest wave within the 5 wave structure, and considering we are currently in a correction within the 3rd wave, I couldn't think of a better, risk managed to perfection, play. ARK investment has been investing heavily into this stock over the last few months, and this is what initially brought me to the stock, and now I can see why. With the 1st wave reaching highs of 675, a current price of 470 roughly is just perfect for an entry point. I see this as being an easy 100% return stock, very likely more. This is not investment advice, please do your own due diligence. I hope this helps, please give me your opinions in the comment section
NASDAQ:REGNLong
by ASA2001
GILD - The Sleeping Giant - Trend ReversalGILD - The Sleeping Giant - Trend Reversal ___________________ ENTRY = 56.56 Double Bottom - +64 confirmation 1st Target = .236fib@72.33 2nd Target = .382fib@82.08 3rd Target = .5fib@89.97 HOLD Target = .618@97.85+ JAN22 Call Leaps Still cheap ________________________________________________________________________________________________________________________ This content is for informational and educational purposes only. This is not in any way, shape or form financial or trading advice. Good luck, happy trading and stay chill, 2degreez
NASDAQ:GILDLong
by UnknownUnicorn7216011
Regeneron's Covid Treatment First Drug Authorized By FDAMy last chart: November 22, 2020: Regeneron's Coronavirus Treatment Becomes First Antibody Cocktail to Earn Emergency Use Authorization from FDA (The Motley Fool). Regeneron Covid Drug Gets Emergency OK. Antibody drug cocktail casirivimab and imdevimab are allowed for use by people over age 12 with mild or moderate Covid-19. (the street). If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:REGNLong
by TopgOptions